E-cadherin Increasing Multidrug Resistance Protein 1 Via Hypoxia-inducible Factor-1α Contributes to Multicellular Resistance in Colorectal Cancer
Overview
Authors
Affiliations
When cancer cells have been cultured as three-dimensional (3D) cultures or in vivo, they decrease sensitivity to anticancer drugs. This is called multicellular resistance, and the mechanism is not fully understood. Here, we report that E-cadherin increasing multidrug resistance protein 1 (MDR1) via hypoxia-inducible factor-1α (HIF-1α) contributes to multicellular resistance in colorectal cancer. The MDR1 protein level was higher in 3D cultures than in monolayer cells. When dispersed cells from 3D cultures were grown as monolayer cells again, the MDR1 protein level decreased to the similar level of cells maintained as monolayer all through. Knockdown of MDR1 significantly decreased multicellular resistance. Knockdown of E-cadherin decreased MDR1 in 3D cultures but did not detectably change MDR1 in monolayer cells. E-cadherin was expressed uniformly in 3D cultures while the MDR1 protein level was higher in the center of 3D cultures than in the peripheral part. Knockdown of E-cadherin decreased E-cadherin uniformly in 3D cultures but mainly decreased MDR1 at the center of 3D cultures. These suggest that knockdown of E-cadherin decreasing MDR1 may be by an indirect mechanism. HIF-1α was remarkably increased in 3D cultures. Knockdown of E-cadherin decreased intercellular junctions, increased intercellular space, and decreased HIF-1α in 3D cultures. Knockdown of HIF-1α decreased MDR1 in 3D cultures. Knockdown of E-cadherin increased β-catenin uniformly in 3D cultures, and knockdown of β-catenin decreased MDR1 what was opposite to knockdown of E-cadherin decreasing MDR1. Our data reveal that knockdown of E-cadherin decreasing MDR1 via HIF-1α is involved in the mechanism of multicellular resistance in colorectal cancer. Though β-catenin is also involved in the mechanism, it does not play a dominant role.
3D stem-like spheroids-on-a-chip for personalized combinatorial drug testing in oral cancer.
Mehta V, Vilikkathala Sudhakaran S, Nellore V, Madduri S, Rath S J Nanobiotechnology. 2024; 22(1):344.
PMID: 38890730 PMC: 11186147. DOI: 10.1186/s12951-024-02625-y.
Possible Mechanisms of Resistance Development to Photodynamic Therapy (PDT) In Vulvar Cancer Cells.
Mossakowska B, Fabisiewicz A, Tudek B, Siedlecki J Int J Mol Sci. 2022; 23(23).
PMID: 36499013 PMC: 9741432. DOI: 10.3390/ijms232314689.
Spheroid Culture Differentially Affects Cancer Cell Sensitivity to Drugs in Melanoma and RCC Models.
Filipiak-Duliban A, Brodaczewska K, Kajdasz A, Kieda C Int J Mol Sci. 2022; 23(3).
PMID: 35163092 PMC: 8835769. DOI: 10.3390/ijms23031166.
Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma.
DePalma T, Sivakumar H, Skardal A Adv Drug Deliv Rev. 2021; 180:114067.
PMID: 34822927 PMC: 10560581. DOI: 10.1016/j.addr.2021.114067.
Xuan Z, Chen C, Tang W, Ye S, Zheng J, Zhao Y Front Cell Dev Biol. 2021; 9:726535.
PMID: 34350190 PMC: 8327907. DOI: 10.3389/fcell.2021.726535.